BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 17522369)

  • 1. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates.
    Brown RE; Tan D; Taylor JS; Miller M; Prichard JW; Kott MM
    Ann Clin Lab Sci; 2007; 37(2):141-7. PubMed ID: 17522369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in Ewing family of tumors.
    Zenali MJ; Zhang PL; Bendel AE; Brown RE
    Ann Clin Lab Sci; 2009; 39(2):160-6. PubMed ID: 19429803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.
    Brown RE; Zhang PL; Lun M; Zhu S; Pellitteri PK; Riefkohl W; Law A; Wood GC; Kennedy TL
    Ann Clin Lab Sci; 2006; 36(3):273-82. PubMed ID: 16951268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications.
    Brown RE; Law A
    Ann Clin Lab Sci; 2006; 36(4):421-6. PubMed ID: 17127728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
    Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
    Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation.
    Zhang H; Ding J; Fan Q; Liu S
    Exp Biol Med (Maywood); 2009 Sep; 234(9):1029-36. PubMed ID: 19546355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
    Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP
    Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
    BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
    Grozinsky-Glasberg S; Franchi G; Teng M; Leontiou CA; Ribeiro de Oliveira A; Dalino P; Salahuddin N; Korbonits M; Grossman AB
    Neuroendocrinology; 2008; 87(3):168-81. PubMed ID: 18025810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
    Guo C; Gasparian AV; Zhuang Z; Bosykh DA; Komar AA; Gudkov AV; Gurova KV
    Oncogene; 2009 Feb; 28(8):1151-61. PubMed ID: 19137016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
    Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages.
    Bae EM; Kim WJ; Suk K; Kang YM; Park JE; Kim WY; Choi EM; Choi BK; Kwon BS; Lee WH
    Mol Immunol; 2008 Jan; 45(2):523-33. PubMed ID: 17602748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
    Abdou AG; Hanout HM
    J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acetoxycycloheximide.
    Ogura H; Tsukumo Y; Sugimoto H; Igarashi M; Nagai K; Kataoka T
    Int Immunopharmacol; 2008 Jun; 8(6):922-6. PubMed ID: 18442799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term ethanol exposure impairs neuronal differentiation of human neuroblastoma cells involving neurotrophin-mediated intracellular signaling and in particular protein kinase C.
    Hellmann J; Rommelspacher H; Wernicke C
    Alcohol Clin Exp Res; 2009 Mar; 33(3):538-50. PubMed ID: 19120063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.
    Wang HJ; Cao JP; Yu JK; Zhang LC; Jiang ZJ; Gao DS
    Eur J Pharmacol; 2008 Oct; 595(1-3):7-12. PubMed ID: 18703048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.